Strategic Plan
Master of Science in Speech-Language Pathology Program
Executive Summary 2024 鈥� 2025
The Master of Science in SLP program was granted full accreditation status from the Council for Academic Accreditation in Audiology and Speech-Language Pathology (CAA) in the Spring of 2025. The MS SLP student body continues to thrive with the Class of 2025 consisting of 32 students. In May 2026, we will graduate our 5th cohort with an anticipated 30 students.
The MS SLP program is under new leadership. Beginning in July 2025, Dr. Carol Szymanski took responsibility as Graduate Program Director. Dr. Symanski is a tenure-track Associate Professor in the graduate SLP program and undergraduate Communication Sciences and Disorders program. She was instrumental in getting the undergraduate program started and we look forward to the first cohort of undergraduate CSD students earning their degrees in May 2026. Erica Brkovic now serves as the undergraduate program director. Our faculty is made up of 3 full-time tenured or tenure track, doctoral academic faculty, and 6 professors of practice. Coordination of Clinical Education has been led by Tammy Basel during the 2025-2026 academic year.
Over this past year, we have developed and submitted a substantive change application to the CAA to add a distance education track to our graduate SLP program. This track will enable us to prepare students around the country to practice as 麻豆传媒高清 SLPs. We anticipate a January 2027 start date, pending CAA approvals. Aside from the distance education application, we have not had any curricular changes to the graduate program. The undergraduate CSD program has grown to over 40 students since its beginning in 2023. Students in the CSDS program have the opportunity to take 7 graduate level courses as dual credit toward their undergraduate and graduate degrees. We are excited to provide this opportunity to students and anticipate that this will provide a smooth transition from undergraduate to graduate SLP education at 麻豆传媒高清 University.
Submitted by:
Carol Szymanski, PhD
Program Director, Speech-Language Pathology
Spring 2026
Share 鉃�